Table 1. Baseline characteristics for HIV-infected patients not infected through intravenous drug use (IDU).
| Demography | Median | Range (5%; 95% percentiles) | N total |
| Age (years) | 44.3 | 29.5; 64.2 | 992 |
| Sex (men) | 74.9% | 992 | |
| European descent | 76.0% | 992 | |
| HIV-related Factors | |||
| HIV duration (years) | 9.2 | 0.6; 21.8 | 992 |
| Nadir CD4 (cells/µL) | 183.0 | 9.0; 476.0 | 959 |
| Nadir CD4<200 cells/µL | 55.6% | 959 | |
| Current cART | 84.7% | 990 | |
| Never cART | 13.0% | 990 | |
| Total treatment duration (years) | 6.7 | 0.5; 10.8 | 861 |
| CD4<350 cells/µL | 21.2% | 949 | |
| HIV RNA (copies/mL) | 39.0 | 39.0; 5110.0 | 942 |
| HIV RNA≤40 copies mL | 72.8% | 942 | |
| Lifestyle | |||
| Current daily smoking | 35.1% | 428 | |
| Waist circumference (cm) | 91.5 | 72.0; 110.5 | 415 |
| BMI (kg/m2) | 23.9 | 19.1; 31.7 | 465 |
| Metabolic syndrome | 30.6% | 366 | |
Abbreviations: cART: Combination antiretroviral treatment; BMI: Body mass index.